Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-23-031841

Director acquired 6,027 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Hatfield Jeffrey S. Director 2023-05-22 Grant or award +6,027 15,806 D
Derivatives
Hatfield Jeffrey S. Director 2023-05-22 Grant or award · Stock Option (Right to Buy) +12,054 12,054 D
Loading xslF345X04/doc4.xml…